Navigation Links
ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
Date:12/6/2011

a attacks in adults and adolescents with hereditary angioedema (HAE), and routine prevention of angioedema attacks in adults and adolescents with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments or patients who are inadequately managed with repeated acute treatment. Cinryze is for intravenous use only.

Severe hypersensitivity reactions to Cinryze may occur.  Thrombotic events have occurred in patients receiving Cinryze, and in patients receiving off-label high dose C1 inhibitor therapy.  Monitor patients with known risk factors for thrombotic events.  With any blood or plasma derived product, there may be a risk of transmission of infectious agents, e.g. viruses and, theoretically, the CJD agent. The risk has been reduced by screening donors for prior exposure to certain virus infections and by manufacturing steps to reduce the risk of viral transmission including pasteurization and nanofiltration. 

The most common adverse reactions in clinical trials associated with Cinryze were rash, headache, nausea, erythema, phlebitis and local reactions at the injection site.  Adverse events of sinusitis and upper respiratory infection also were observed in clinical trials.  No drug-related serious adverse events (SAEs) were reported in clinical trials.

Please visit http://www.viropharma.com/products/cinryze.aspx for the full U.S. Prescribing Information; the prescribing information for other countries can be found at www.viropharma.com. 

About Enhanze™ Technology

Enhanze™ technology is a proprietary drug delivery platform using Halozyme's first approved enzyme, recombinant human hyaluronidase or rHuPH20. When formulated with other injectable drugs, Enhanze technology can facilitate the
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ViroPharma to Participate in Two November Healthcare Investor Conferences
2. ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline
3. ViroPharma Incorporated Reports Third Quarter 2011 Financial Results
4. ViroPharma to Release 2011 Third Quarter Financial Results on October 27, 2011
5. ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreichs Ataxia
6. ViroPharma Announces Additional Securities Repurchase Program
7. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
8. ViroPharmas Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
9. ViroPharma to Participate in the Stifel Nicolaus 2011 Healthcare Conference
10. ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union
11. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Amgen (NASDAQ: AMGN ) will ... Conference on Thursday, May 30, 2013, at the Westin Boston ... a.m. Eastern Daylight Time. Arvind Sood , ... the conference. Live audio of the presentation can be accessed ... under Investors. A replay of the webcast will also be ...
(Date:5/23/2013)... , May 23, 2013  A recently published ... Houston, Texas , demonstrates that 3D ... increasing cancer detection. The study, "Implementation ... Observational Study," was led by Stephen L. ... issue of the American Journal of Roentgenology ...
(Date:5/23/2013)... Anthem Blue Cross patients with HIV/AIDS may ... to obtain their medications by mail order under a ... LLC.  The lawsuit, filed in January ... mandatory mail order program announced late last year illegally ... "This settlement brings to a close a nerve-racking ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
(Date:5/25/2013)... 25, 2013 This week idcloak Technologies releases ... Facebook in countries where the site is blocked. When ... faces none of the site compatibility problems associated with regular ... explains how a user may apply IP Port proxies to ... benefits of doing so are. , “When a user takes ...
(Date:5/25/2013)... Imagine running the air conditioner with the ... air and wasted energy! If the home has a folding ... clothes dryer, that may be just what is occurring in ... holes waste energy in the form of higher energy bills. ... in the home. , Drafts occur through the small cracks ...
(Date:5/25/2013)... May 25, 2013 It's not astonishing ... the year. The demands are endless, from family, friends ... buy, children who want more than their parents can ... after holiday season, comes graduations, birthdays, anniversaries and it ... some point gift ideas become tired and income can’t ...
(Date:5/25/2013)... Chandler, AZ (PRWEB) May 25, 2013 ... whitening service page in partnership with JD Media Surge, ... whitening methods are now available and, depending on the ... home. During a routine visit, the best method will ... whitening is performed during a visit. A special peroxide-based ...
(Date:5/25/2013)... Communities of Distinction TV announces May air ... media market in the United States with almost three million ... Texas and a major convention city. Ft. Worth is known ... is home to many major museums. Both cities offer a ... arts. Residents and locals will be able to watch the ...
Breaking Medicine News(10 mins):Health News:idcloak Launches Proxy Web Browser for Blocked Facebook Users 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4Health News:TheBeautyPlace.com Debuts Their Brand New Beauty Kits 2Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2
... class of drugs for treating,type 2 diabetes is under ... for Clinical Evaluative Sciences (ICES) finds that drugs such,as ... and death., Published in the December 12th issue ... drugs including rosiglitazone (Avandia) and,pioglitazone (Actos) in the first ...
... Early identification of adverse effects of drugs before they ... therapeutics, as unexpected effects account for a third of ... researchers at the University of California, San Diego (UCSD) ... identify potential side effects of pharmaceuticals, and have used ...
... -- In as many as one in five people ... blood around the body, some degree of backward leakage ... mitral regurgitation (MR). When sufficiently severe, MR causes buildup ... breathing (dyspnea, or "shortness of breath"), a serious condition ...
... predictor of heart disease, Britsh study says , TUESDAY, Dec. ... risk factor for heart disease, say British researchers who also ... of heart disease risk than waist measurement alone. , ... , included 24,508 men and women, ages 45 to 79, ...
... achievements place the field of microresonators at the ... issue of Optics Express, papers explore advanced silicon ... applications and the longest photon lifetime in a ... to Dr. Vasily Astratov from the University of ...
... is a familiar scenario experienced around the world: an outbreak ... one knows where it came from or how to stop ... people are affected, most often the very old and the ... fall ill, and people who were weak or unwell may ...
Cached Medicine News:Health News:More evidence suggests diabetes drug may be dangerous 2Health News:More evidence suggests diabetes drug may be dangerous 3Health News:New computational technique can predict drug side effects 2Health News:Exercise testing may help predict seriousness of mitral regurgitation 2Health News:Abdominal Fat Tied to High Risk for Coronary Trouble 2Health News:IBM reports milestone in silicon nanophotonics 2Health News:Scientists seek to assess the microbial risks in the water we drink 2Health News:Scientists seek to assess the microbial risks in the water we drink 3
... SofPort Advanced Optics Aspheric Lens System ... one IOL all your cataract patients ... vision quality and contrast sensitivity. With ... AO should consistently deliver superior optical ...
... Defibrillator was designed to be as easy ... and shares many of its features, including ... Philips HeartStart Home Defibrillator is an automated ... home use by untrained users. Although small ...
... Brilliance 64-channel configuration breaks through previous ... volume, thin-slice coverage to improve diagnostic ... ,With 40mm of thin-slice coverage, the ... allowing for unprecedented coronary artery evaluation. ...
Designed to meet the demanding requirements of scientific and laboratory,applications. Special cabinet incorporates industrial quality with a,heavy duty refrigeration system to maintain your valu...
Medicine Products: